Literature DB >> 12057634

Studies on scavenger receptor inhibitors. Part 1: synthesis and structure-activity relationships of novel derivatives of sulfatides.

Kazuya Yoshiizumi1, Fumio Nakajima, Rika Dobashi, Noriyasu Nishimura, Shoji Ikeda.   

Abstract

Scavenger receptors have been proven to be implicated in the formation of atherosclerotic lesions. A series of novel derivatives of sulfatides were synthesized, and their inhibitory activities against incorporation of DiI-acetyl-LDL into macrophages were evaluated in order to clarify the structure-activity relationships of sulfatides as a scavenger receptor inhibitor and find out novel inhibitors with synthetic easiness. The chemical modification of the substructures of sulfatides led to the establishment of the following structure-activity relationships; (1) the ceramide moiety can be replaced with another structure bearing two long chains, (2) the galactose moiety can be replaced with another structure or be deleted without a large decrease in the inhibitory activity, (3) the sulfate moiety was crucial, and it was the most preferable functional group for a potent inhibitory activity. The inhibitory activity of (S)-2-octadecanoylamino-2-tetradecylcarbamoyl)ethyl sulfate sodium salt (3a) against incorporation of DiI-acetyl-LDL into macrophages was proven to be based on the inhibition against the binding of acetyl-LDL to the surface of macrophages. We discovered novel scavenger receptor inhibitors with synthetic easiness, such as (S)-2-octadecanoylamino-2-(tetradecylcarbamoyl)ethyl sulfate sodium salt (3a) and 2-octadecanoylamino-1-(octadecanoylaminomethyl)ethyl sulfate sodium salt (13q).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12057634     DOI: 10.1016/s0968-0896(02)00120-7

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Controllable inhibition of cellular uptake of oxidized low-density lipoprotein: structure-function relationships for nanoscale amphiphilic polymers.

Authors:  Nicole M Iverson; Sarah M Sparks; Bahar Demirdirek; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Acta Biomater       Date:  2010-02-17       Impact factor: 8.947

2.  Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity.

Authors:  Neal K Bennett; Rebecca Chmielowski; Dalia S Abdelhamid; Jonathan J Faig; Nicola Francis; Jean Baum; Zhiping P Pang; Kathryn E Uhrich; Prabhas V Moghe
Journal:  Biomaterials       Date:  2016-10-04       Impact factor: 12.479

3.  Sulfated glycosphingolipid as mediator of phagocytosis: SM4s enhances apoptotic cell clearance and modulates macrophage activity.

Authors:  Zoran V Popovic; Roger Sandhoff; Tjeerd P Sijmonsma; Sylvia Kaden; Richard Jennemann; Eva Kiss; Edgar Tone; Frank Autschbach; Nick Platt; Ernst Malle; Hermann-Josef Gröne
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

4.  Methylation-induced downregulation of TFPI-2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinoma.

Authors:  Junko Hamamoto; Kenzo Soejima; Katsuhiko Naoki; Hiroyuki Yasuda; Yuichiro Hayashi; Satoshi Yoda; Sohei Nakayama; Ryosuke Satomi; Hideki Terai; Shinnosuke Ikemura; Takashi Sato; Daisuke Arai; Kota Ishioka; Keiko Ohgino; Tomoko Betsuyaku
Journal:  Cancer Sci       Date:  2014-12-08       Impact factor: 6.716

Review 5.  Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy.

Authors:  Yi Wang; Kai Conrad Cecil Johnson; Margaret E Gatti-Mays; Zihai Li
Journal:  J Hematol Oncol       Date:  2022-08-28       Impact factor: 23.168

6.  The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity.

Authors:  Zaida G Ramirez-Ortiz; William F Pendergraft; Amit Prasad; Michael H Byrne; Tal Iram; Christopher J Blanchette; Andrew D Luster; Nir Hacohen; Joseph El Khoury; Terry K Means
Journal:  Nat Immunol       Date:  2013-07-28       Impact factor: 25.606

7.  Structure-based Design Targeted at LOX-1, a Receptor for Oxidized Low-Density Lipoprotein.

Authors:  Shraddha Thakkar; Xianwei Wang; Magomed Khaidakov; Yao Dai; Kuppan Gokulan; Jawahar L Mehta; Kottayil I Varughese
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.